Pagoclone going the Zoloft way?
Executive Summary
Pfizer nearly rejected Zoloft clinical development twice before going on to market the drug, Indevus tells conference call on Pfizer's termination of pagoclone contract. "Twice in the history of Zoloft, in the early days at Pfizer, the compound was facing cancellation over dose and efficacy issues and obviously Zoloft came through to be one of the most successful antidepressants today," the company said...